At Ferozsons, it's your health before anything else! We strive to attain market leadership by putti fields. The new wing will be operational in early 2013.
The Corporate History of the Ferozsons Group began in 1894, when its Founder Maulvi Ferozuddin Khan established the Ferozsons publishing house. From the outset, our founder’s corporate vision involved playing a meaningful role in the education and health of the underprivileged population of the sub-continent. Consequently, Ferozsons Laboratories Limited was created in 1954 as one of the first ph
armaceutical manufacturing facilities in the fledgling state of Pakistan. The company commenced operations in 1956, and in 1960 became the first Pakistani pharmaceutical company to be lister on the Karachi Stock Exchange. We have a consistent track record of financial performance, and are a 6-time recipient of the Karachi Stock Exchange's 'KSE Top 25 Companies Award.'
Through our range of branded generics and in-licensed products , we have attained market leadership in the areas of cardiology , oncology, gastroenterology, dermatology and anti-infective markets in the Pakistan. These products are now being exported to markets in Asia and Africa, and we are actively seeking export opportunities in other markets. Ferozsons is the Pakistan marketing and distribution partner for the Boston Scientific Corporation, USA for its range of cardiac and peripheral products and interventional devices. This partnership will allow us to further strengthen our channels in cardiology , oncology, and G.I. We offer principals an excellent manufacturing, marketing and distribution platform for launching their products in the Pakistan market. Our cGMP compliant production facility in Nowshera is ISO 9001 certified and we are fully equipped with state of the art manufacturing and testing equipment. The facility consists of independent sections, each with its own dedicated air handling system to avoid cross-contamination between different classes of drugs being manufactured. Our production capabilities include the manufacturing of tablets, capsules, syrups, suspensions, creams and ointments. Our facility control laboratory is among the best equipped in the industry and possesses Malver Particle Size Analyzers, High Performance Liquid Chromatographs (HPLC), Gas Chromatograph (GC), Fourier Transfer-IR Spectrophotometer and UV-Visible spectrometers, in addition to dissolution, disintergration, hardness and friability testers. In 2012, the Company undertook a major expansion in its manufacturing, adding a new production wing for the production of solid dosage forms.
09/04/2026
BF Biosciences Limited was privileged to host the delegation from the Supreme Board of Drugs and Medical Appliances (SBDMA), , for a comprehensive inspection of our manufacturing facility.
This visit underscores our unwavering commitment to upholding the highest standards of , , and in pharmaceutical manufacturing. We greatly value the constructive dialogue and insights shared throughout the audit process, reinforcing our continuous pursuit of excellence.
We extend our sincere appreciation to our team and our distribution partners in for their collaboration and dedication in ensuring the success of this engagement.
At BF Biosciences Limited, we remain focused on strengthening global regulatory partnerships—delivering safe, high-quality medicines while advancing healthcare outcomes worldwide.
08/04/2026
This , our teams at Ferozsons Laboratories Limited and BF Biosciences Limited came together for an engaging and insightful session on “Together for Health: Stand with Science.” Led by Mr. Adnan Farooq, an expert in functional medicine and wellness. We had an engaging, activity-based discussion on Wellness 2.0—rethinking how we approach our health today—with a strong focus on longevity and presenteeism in the workplace.
Through an interactive and thought-provoking activity, employees reflected on their own health choices, reinforcing the importance of being not just present, but truly well.
Because real impact begins from within — informed, empowered, and guided by science.
Our commitment is simple — , , and .
28/03/2026
Today, we come together for — 28th March, 8:30 PM to 9:30 PM.
As we switch off our lights, we also switch on our commitment to sustainability, responsibility, and collective action. This year, let’s go beyond the hour. Give an hour for Earth — whether through small mindful actions or conscious choices that support our environment and, ultimately, our health.
Because protecting our planet means protecting our future.
Earth Hour
25/03/2026
Since 2022, our annual Heart Summit has been committed to advancing the science and practice of cardiovascular care—and the 2026 continues that legacy.
Bringing together cardiologists and healthcare professionals, this year’s summit was held in . The theme for the year, "Dilemma of Cardiovascular Continuum", focused on strengthening clinical capacity through integrated, evidence-based approaches to managing cardiovascular disease.
From foundational education about heart failure to advanced acute coronary syndrome and integrated multidisciplinary management, the conversations centred on translating scientific advancements into real-world impact - Improving Patient Lives.
24/03/2026
Yes! We Can End TB!
With 10.7 million people falling ill with TB and 1.23 million lives lost in 2024, the urgency to act has never been greater. Ending requires more than awareness — it calls for action.
Let’s work together to:
✔️ End TB
✔️ Know the symptoms
✔️ Get tested early
✔️ Follow treatment plans
Because with collective effort, stronger commitment, and timely action — ending is within reach.
Source:WHO
24/03/2026
As we return to work, we are carrying forward the joy, gratitude, and warmth that the festive days brought. It’s refreshing to return to familiar routines while still holding onto moments of celebration — from shared wishes and smiles to sweet treats at Ferozsons Laboratories Head Office.
Staying connected and celebrating together. Eid Mubarak!!
21/03/2026
Eid Mubarak!!
Ferozsons Laboratories wishes you and your loved ones joy, peace and health.
13/03/2026
On World Obesity Day, our teams at Ferozsons Laboratories Limited and BF Biosciences Limited came together to reflect on this year’s theme: 8 Billion Reasons to Act on Obesity.
Through a series of engaging office activities, our employees participated in BMI screenings and one-on-one consultations with a clinical nutritionist.
As Childhood Obesity is increasing rapidly, a poster competition highlighting childhood obesity awareness was held for employees and their loved ones.
A special highlight of the day was a live podcast with Prof. Dr. Maaz ul Hassan (Consultant Laparoscopic, General and Obesity surgeon), Head of Department, Shalamar Hospital. The open platform led to healthy discussions on the realities and solutions around obesity.
Together, we continue to build awareness and encourage healthier choices — because every action counts in changing the story of obesity.
We all have our reasons to change the story of obesity. What’s yours?
12/03/2026
Ferozsons Laboratories Limited & BF Biosciences Limited successfully convened high-level , bringing together leading , , and Consultant Physicians.
The forum enabled deep, evidence-based dialogue around /GIP, enriched by real-world and robust peer discussion on of the WHY, WHERE, and HOW of .
The deliberations strongly emphasised the importance of a paradigm—where is complemented by dietary optimisation and structured physical activity—to achieve sustainable .
12/03/2026
On International Women’s Day, we celebrate the contributions, resilience, and achievements of women worldwide.
Because when we give respect, opportunity, and encouragement, we all gain.
12/03/2026
Did you know? affects 1 in 10 people worldwide.
Environmental challenges such as air pollution, heat stress, dehydration, and extreme weather events increase the risk of and speed up its progression. At the same time, treatments for end-stage kidney disease, particularly , require large amounts of water, energy, and single-use plastics, placing an added burden on the environment.
This , lets prioritize prevention, , and greener therapies, so we can protect both our kidney health and our planet.
Ferozsons Laboratories Limited extends warm wishes to the people of on the occasion of . May this day celebrate freedom, resilience, and continued progress for the nation.
Be the first to know and let us send you an email when Ferozsons Laboratories Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
The foundations of the Ferozsons business group were laid in 1894 by Maulvi Ferozuddin Khan, who founded the Ferozsons publishing house. From the outset, the group’s corporate vision involved playing a meaningful role in the education and health of the underprivileged population of the sub-continent. Ferozsons Laboratories Limited was thus established in 1956 as one of the first Pharmaceutical manufacturing companies in Pakistan, and has now entered its seventh decade of serving the cause of health and well- being in Pakistan and a growing number of international markets.
In 1960, we became the first Pakistani pharmaceutical company to be listed on the Karachi Stock Exchange (KSE) Limited, and have a consistent track record of delivering on our financial objectives. The company is a multiple-time recipient of the KSE Top 25 Companies Award.
Ferozsons set the standards for the strict adherence to Global Standards of Quality Control and Good Manufacturing Practices, achieving International acclaim and recognition soon after its incorporation. The company remained a major supplier to the Federal Supply Services, Government of U.S.A, The British Crown Agents, the United Nations, various international relief agencies besides exporting to many developed countries including Australia, Iran, Hong Kong, Jordan, Saudi Arabia, Singapore, Sri Lanka, Sudan, Tanzania, Thailand, Turkey and the U.A.E.
The company has a long and highly successful history of collaborations with various multinational companies in the past, including Boots Pharmaceuticals PLC of U.K, Chemie Grunenthal GmbH, Germany, Lakeside laboratories U.S.A, Orgasynth Laboratories of France and Proctor & Gamble, U.S.A.
Now the company has expanded its portfolio of medical solutions for critical diseases by forging alliances with some of the world’s most innovative companies including Gilead Sciences, Inc., a global leader in the treatment of HIV and Viral Hepatitis, the Boston Scientific Corporation, USA the world’s leading manufacturer of medical devices, and a joint venture in biopharmaceuticals with the Bagó Group of Argentina. We also have partnerships with BioGaia of Sweden for a line of probiotics as well as Performance Health, Inc. USA for the brand, Biofreeze pain relief products.
